CMS re­veals 34 Medicare drugs sub­ject to in­fla­tion re­bates un­der IRA next quar­ter

The fed­er­al gov­ern­ment has re­leased the lat­est round of Medicare coin­sur­ance sav­ings un­der the In­fla­tion Re­duc­tion Act’s re­bate pro­gram.

The leg­is­la­tion en­act­ed last sum­mer re­quires re­bates to Medicare on cer­tain drugs with prices ris­ing faster than the rate of in­fla­tion. A to­tal of 34 Part B drugs will have ad­just­ed coin­sur­ance rates for the Oct. 1 to Dec. 31 pe­ri­od, re­sult­ing in sav­ings for se­niors be­tween $1 and $618 per av­er­age dose, ac­cord­ing to CMS, high­er than last quar­ter’s max­i­mum $449 per av­er­age dose de­spite a slight­ly short­er list.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER